Haemonetics Corporation: capex
| Value | {"amount": 191327000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2022-04-03 – 2023-04-01 |
| Status | current |
| Entity | Haemonetics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/700442b3-6244-454c-b0d0-3b2407b4e52c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000313143-25-000025Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000313143/capex/2023-04-01 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/700442b3-6244-454c-b0d0-3b2407b4e52c
History
- supersedes {"amount": 110191000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0000313143-23-000014)